Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mohawk Industries | MHK | Apr 19, 2024 | 108.88 | +0.74 |
Molecular Partners ADR | MOLN | Apr 19, 2024 | 3.32 | -11.23 |
Molecular Templates | MTEM | Apr 19, 2024 | 1.47 | -1.01 |
Moleculin Biotech | MBRX | Apr 19, 2024 | 4.65 | +2.80 |
Molina Healthcare | MOH | Apr 19, 2024 | 367.52 | +1.82 |
Molson Coors B | TAP | Apr 19, 2024 | 64.23 | +0.55 |
Molson Coors Beverage Company A | TAP-A | Apr 19, 2024 | 67.70 | 0.00 |
Momentus A | MNTS | Apr 19, 2024 | 0.37 | -0.70 |
Monarch Casino & Resort | MCRI | Apr 19, 2024 | 67.34 | +1.20 |
Monday.com | MNDY | Apr 19, 2024 | 178.07 | -3.80 |
Mondee | MOND | Apr 19, 2024 | 2.19 | +4.78 |
Mondelez International A | MDLZ | Apr 19, 2024 | 68.11 | +1.40 |
Moneyhero | MNY | Apr 19, 2024 | 2.05 | -1.44 |
MoneyLion A | ML | Apr 19, 2024 | 69.13 | -4.48 |
MongoDB A | MDB | Apr 19, 2024 | 327.47 | -2.41 |
Monogram Orthopaedics | MGRM | Apr 19, 2024 | 2.25 | -0.44 |
Monolithic Power Systems | MPWR | Apr 19, 2024 | 591.52 | -4.64 |
Monopar Therapeutics | MNPR | Apr 19, 2024 | 0.64 | -5.59 |
Monro | MNRO | Apr 19, 2024 | 29.58 | -0.54 |
Monroe Capital | MRCC | Apr 19, 2024 | 7.13 | +1.21 |
Monster Beverage | MNST | Apr 19, 2024 | 53.14 | -0.60 |
Montana Technologies A | AIRJ | Apr 19, 2024 | 10.30 | 0.00 |
Montauk Renewables | MNTK | Apr 19, 2024 | 3.48 | +1.46 |
Monte Rosa Therapeutics | GLUE | Apr 19, 2024 | 5.85 | -1.18 |
Montrose Environmental Group | MEG | Apr 19, 2024 | 40.20 | -4.10 |
Moodys | MCO | Apr 19, 2024 | 374.67 | +0.02 |
Moog A | MOG-A | Apr 19, 2024 | 153.87 | +0.75 |
Moog B | MOG-B | Apr 19, 2024 | 155.07 | 0.00 |
Moolec Science | MLEC | Apr 19, 2024 | 1.40 | +1.45 |
MoonLake Immunotherapeutics | MLTX | Apr 19, 2024 | 42.19 | -0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.